12 concentração dos hormônios esteroides no fluido folicular de folículos ovarianos maduros e imaturos de pacientes com síndrome dos ovários policísticos submetidas à fertilização in vitro concentration of steroid hormones in the follicular fluid of mature and immature ovarian follicles of patients with polycystic ovary syndrome submitted to in vitro fertilization

13 polycystic ovary syndrome in the practice of a teenage gynecologist: the possibility of prevention, the principles of therapy

14 sexual orientations of women with polycystic ovary syndrome: clinical observation in taiwan

15 comparing the effect of aqueous extract of green tea and catechin on gonadotropins, β-estradiol, progesterone, testosterone and ovarian follicle in polycystic ovarian syndrome rat model

16 relationship between fas rs1800682 gene polymorphism and susceptibility to polycystic ovary syndrome

17 an investigation of biochemical and structural changes in reproductive system hyperandrogenism in experimental letrozole-induced polycystic ovary syndrome in rat

18 polycystic ovary syndrome in patients on antiepileptic drugs

19 Interleukin-22/Interleukin-22 binding protein axis and oral contraceptive use in polycystic ovary syndrome.

20 Effect of Calcium and Vitamin D Supplements as an Adjuvant Therapy to Metformin on Menstrual Cycle Abnormalities, Hormonal Profile, and IGF-1 System in Polycystic Ovary Syndrome Patients: A Randomized, Placebo-Controlled Clinical Trial

21 The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome

22 Using of rm-anova in r and spss software on the example of prospective analysis of glucose tolerance test results in patients with polycystic ovary syndrome

23 A low glycemic index decreases inflammation by increasing the concentration of uric acid and the activity of glutathione peroxidase (GPX3) in patients with polycystic ovary syndrome (PCOS)

24 Association Between Vitamin D and Adrenal Parameters with Metabolic and Inflammatory Markers in Polycystic Ovary Syndrome

25 Early pregnancy metabolic factors associated with gestational diabetes mellitus in normal-weight women with polycystic ovary syndrome: a two-phase cohort study.

26 Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety.

27 Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility.

28 Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.

29 Genome-wide methylation profiling in granulosa lutein cells of women with polycystic ovary syndrome (PCOS).

30 Impact of vitamin D supplementation on cardio-metabolic status and androgen profile in women with polycystic ovary syndrome: placebo-controlled clinical trial

31 Ovarian Expression of Adipokines in Polycystic Ovary Syndrome: A Role for Chemerin, Omentin, and Apelin in Follicular Growth Arrest and Ovulatory Dysfunction?

32 Quantitative mass spectrometric analysis to unravel glycoproteomic signature of follicular fluid in women with polycystic ovary syndrome.

33 The effect of prednisolone on endometrial VGEF concentrations, Gene polymorphisms and pregnancy outcome in women with polycystic ovary syndrome: A retrospective cohort study.

34 Long Non-coding RNA NEAT1 Drives the Development of Polycystic Ovary Syndrome via Sponging Multiple MicroRNAs.

35 Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys

36 Androgen Receptors in Multiple Organ Systems Provide Molecular Gateways to Polycystic Ovary Syndrome

37 Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism

38 Metabolic Inflexibility Is a Feature of Women With Polycystic Ovary Syndrome and Is Associated With Both Insulin Resistance and Hyperandrogenism

39 Developmental origin of polycystic ovary syndrome - a hypothesis

40 Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome

41 Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome

42 Adipocyte biology in polycystic ovary syndrome

43 Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome

44 Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome

45 Developmental Programming: Excess Weight Gain Amplifies the Effects of Prenatal Testosterone Excess On Reproductive Cyclicity—Implication for Polycystic Ovary Syndrome

46 Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women

47 Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

48 Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome

49 Adrenal Hyperandrogenism Is Induced by Fetal Androgen Excess in a Rhesus Monkey Model of Polycystic Ovary Syndrome

50 Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome

51 Developmental origin of polycystic ovary syndrome - a hypothesis

52 Andrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

53 Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

54 The genetics of obesity. Lessons for polycystic ovary syndrome

55 Nonhuman primate models of polycystic ovary syndrome

56 Polycystic ovary syndrome and offspring risk of congenital heart defects: a nationwide cohort study

57 Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

58 Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?

59 Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome

60 Ovulatory effects of flutamide in the polycystic ovary syndrome

61 Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys

62 Menstrual Abnormalities and Polycystic Ovary Syndrome in Women Taking Valproate for Bipolar Mood Disorder

63 Sexual Function in Women With Polycystic Ovary Syndrome: Design of an Observational Prospective Multicenter Case Control Study

64 Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome

65 Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome

66 Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?

67 Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome

68 Lipid and lipoprotein profile in women with polycystic ovary syndrome

69 does carotid intima-media thickness have relationship with polycystic ovary syndrome?

70 the effect of herbal teas on management of polycystic ovary syndrome: a systematic review

71 relationship between serum lipoprotein ratios and insulin resistance in polycystic ovary syndrome

72 analysis of the informativeness of melatonin evaluation in polycystic ovary syndrome

73 diagnostic value of prostate-specific antigen in women with polycystic ovary syndrome

74 is anti-mullerian hormone a good diagnostic marker for adolescent and young adult patients with polycystic ovary syndrome?

75 risk for gestational diabetes mellitus and adverse birth outcomes in chinese women with polycystic ovary syndrome

76 nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: a rct

77 hiperandrogenismo e pele: síndrome do ovário policístico e resistência periférica à insulina hyperandrogenism and skin: polycystic ovary syndrome and peripheral insulin resistance

78 anthropometric characteristics and dietary pattern of women with polycystic ovary syndrome

79 prevalence of polycystic ovary syndrome in young women from north india: a community-based study

80 hirsutism, acne, and hair loss: management of hyperandrogenic cutaneous manifestations of polycystic ovary syndrome

81 risks for gestational diabetes mellitus and pregnancy-induced hypertension are increased in polycystic ovary syndrome

82 does polycystic ovary syndrome itself have additional effect on apelin levels?

83 uso de 150mg/dia de acarbose em pacientes obesas e com síndrome dos ovários policísticos: estudo duplo cego randomizado, com grupo placebo use of 150 mg/day acarbose in obese patients with polycystic ovary syndrome: a double-blind randomized study with a placebo group

84 cardiovascular system diseases in patients with polycystic ovary syndrome – the role of inflammation process in this pathology and possibility of early diagnosis and prevention

85 Consensus on womenâs health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

86 The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited

87 Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone

88 Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome

89 Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys

90 Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats - Journal of Ovarian Research

91 Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome - International Journal of Obesity

92 Polycystic ovary syndrome

93 Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome

94 Naturally Occurring and Experimentally Induced Rhesus Macaque Models for Polycystic Ovary Syndrome: Translational Gateways to Clinical Application

95 A mechanism for the suppression of estrogen production in polycystic ovary syndrome

96 Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming - Clinical Epigenetics

97 Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

98 Do Animal Models of Polycystic Ovary Syndrome Help to Understand Its Pathogenesis and Management? Yes, but Their Limitations Should be Recognized

99 Polycystic ovary syndrome induced by exposure to testosterone propionate and effects of sympathectomy on the persistence of the syndrome - Reproductive Biology and Endocrinology

100 Endocrine Traits of Polycystic Ovary Syndrome in Prenatally Androgenized Female Sprague-Dawley Rats

101 A Single Bout of Electroacupuncture Remodels Epigenetic and Transcriptional Changes in Adipose Tissue in Polycystic Ovary Syndrome - Scientific Reports

Keyword Connections

Journals

Research Groups

Bibliographies